Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community‐Acquired Pneumonia

(2008)   CLINICAL INFECTIOUS DISEASES

Executive Summary: Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs in the Treatment of Community‐Acquired Pneumonia

(2008) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005

(2008) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Superantigen Profile ofStaphylococcus aureusIsolates from Patients with Steroid‐Resistant Atopic Dermatitis

(2008) Patrick M. Schlievert et al.   CLINICAL INFECTIOUS DISEASES

Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

(2008) G. J. Noel et al.   CLINICAL INFECTIOUS DISEASES

Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities

(2008) Carl Urban et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Methicillin‐ResistantStaphylococcus aureus

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

“The truth, if it exists, is in the details”*

(2008) David Gilbert   CRITICAL CARE MEDICINE

What is in the pipeline for Gram-negative pathogens?

(2008) George H Talbot   Expert Review of Anti-Infective Therapy

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria

(2008) Vicente Pintado et al.   JOURNAL OF INFECTION

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

(2008) Louis B. Rice   JOURNAL OF INFECTIOUS DISEASES

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

(2008) Ian Chopra et al.   LANCET INFECTIOUS DISEASES

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES

Trends in disease focus of drug development

(2008) Johan P. E. Karlberg   NATURE REVIEWS DRUG DISCOVERY

Acinetobacter Infection

(2008) L. Silvia Munoz-Price et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Bacteria Fight Back

(2008) G. Taubes   SCIENCE

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia

(2007) K. M. Erlandson et al.   CLINICAL INFECTIOUS DISEASES